'I've Spent £20k on Prostate Cancer Drug - but New Test Could Save NHS Money'

'I've spent £20k on prostate cancer drug - but new test could save NHS money'

Giles Turner, 64, has had high-risk prostate cancer since 2023 and has spent £20,000 on the drug abiraterone (Picture: Giles Turner) A new AI test can detect which men with high-risk prostate cancer could benefit from a life-extending drug. The technology studies images of tumour samples and picks out features the human eye cannot see. It then gives patients a score – biomarker-positive or -negative – to determine who will require abiraterone – …

New AI Test Could Maximize the Possibility of Cure for Prostate Cancer Patients

A novel AI test created by UCL and the Institute of Cancer Research helps determine which men with high-risk, localized prostate cancer will respond positively to the hormone therapy drug abiraterone. Researchers say the test could maximize the possibility of cure and reduce NHS costs by ensuring treatment is only given when it is likely to work, avoiding unnecessary side effects and wasted resources. How the AI test works Researchers at Univers…

ASCO25: AI test shown to aid in prostate cancer treatment planning

New research has shown that the ArteraAI test can help identify which men with non-metastatic high-risk prostate cancer are most likely to benefit from being administered abiraterone.The post ASCO25: AI test shown to aid in prostate cancer treatment planning appeared first on Medical Device Network.

AI test could help to cut the risk of dying from prostate cancer by half, study suggests

Proper news from Britain - News from Britain you won’t find anywhere else. Not the tosh the big media force-feed you every day!